Glucose Transporters in Melanomas and Nevi
Author Information
Author(s): Paola Parente, Antonella Coli, Guido Massi, Antonella Mangoni, Manuela M Fabrizi, Giulio Bigotti
Primary Institution: Catholic University "Sacro Cuore", Rome, Italy
Hypothesis
This study was undertaken to assess the differential expression of Glut-1 and Glut-3 by benign and malignant melanocytic lesions.
Conclusion
The glucose transporters Glut-1 and Glut-3 play a role in the glucose metabolism of melanocytic cells, with Glut-1 being more prevalent in benign nevi than in malignant melanomas.
Supporting Evidence
- Glut-1 was expressed in all melanocytic nevi and the majority of Spitz nevi.
- Glut-1 expression was downregulated in 55% of malignant melanomas.
- Glut-3 was present in all benign and malignant melanocytic lesions.
Takeaway
This study looked at how two proteins that help cells take in sugar are found in both benign and cancerous skin growths, finding that one of them is less common in cancer.
Methodology
Immunohistochemical staining for Glut-1 and Glut-3 was performed on paraffin-embedded tissue sections prepared from melanocytic nevi, Spitz nevi, and primary cutaneous malignant melanomas.
Limitations
The study did not find a significant correlation between Glut-1 expression and the thickness of the tumor.
Participant Demographics
The study included 44 specimens from patients who had undergone surgery for either benign or malignant melanocytic lesions.
Statistical Information
P-Value
0.0118
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website